FDA Recall of Discount Drug Mart Menthol Cough Drops
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA has announced a voluntary recall of Discount Drug Mart Menthol Cough Drops due to potential quality issues identified during a manufacturing inspection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, cpsc, Drugs.
What Happened
The recall was initiated following FDA's recommendation based on observations from an August 15, 2025, inspection of the manufacturing facility that may affect product quality.
Which Products Are Affected
The affected product is Discount Drug Mart Food Market, Cough Drops, Menthol - Cough Suppressant Anesthetic, in 30-count bags. It has NDC: 83698-102-30, UPC: 093351037085, package NDCs: 83698-102-30 and 0933510370, Lot #: 20241030, and Expiration Date: 10/30/2026. The distribution is US Nationwide, with an unknown quantity affected.
What You Should Do
Consumers should check if they have the affected product by verifying the lot number and expiration date, and contact the recalling firm, Xiamen Kang Zhongyuan Biotechnology Co., Ltd., at their address: No. 2018, 2 Jietou Road, Xiamen, China, as the initial notification was via letter.
Why This Matters
This recall highlights potential quality concerns in over-the-counter drugs, which could lead to temporary health issues, affecting consumer trust in nationwide distributed products.
Source
Attribution: FDA Recall Number D-0460-2026. For more information, refer to the FDA's official recall database.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,196 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to May 3, 2026.
Frequently Asked Questions
Common questions about this FDA recall.